The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons

Brain

Volumn 120, Issue 12, 1997, Pages 2159-2169

  Hirota, Nobuyuki ^a   Kaji, Ryuji ^a,d   Bostock, Hugh ^c   Shindo, Katsuro ^a   Kawasaki, Teruaki ^a   Mizutani, Kotaro ^a   Oka, Nobuyuki ^a   Kohara, Nobuo ^a   Saida, Takahiko ^b   Kimura, Jun ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UTANO NATIONAL HOSPITAL   (Japan)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anti GM1 antibody; Conduction block; Demyelination; External longitudinal current; Sodium channel

Indexed keywords

GALACTOSYLCERAMIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; SODIUM; SODIUM CHANNEL; TETRODOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; GUILLAIN BARRE SYNDROME; HUMAN; MEMBRANE CURRENT; MOTOR NERVE; MOTOR NEUROPATHY; NERVE BLOCK; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; VENTRAL ROOT;

EID: 0031468335     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/120.12.2159     Document Type: Article

References (53)

1. Arasaki K, Kusunoki S, Kudo N, Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 1993; 16: 587-93.
2. Bostock H. Impulse propogation in experimental neuropathy. In: Dyke PJ, Thomas PK. Griffin JW, Low PA, Poduslo JS, editors. Peripheral neuropathy, 3rd ed. Philadelphia: Saunders, 1993: 109-20.
3. Bostock H, Sears TA. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J Physiol (Lond) 1978; 280: 273-301.
4. Bouche P, Moulonguet A, Younes-Chennoufi AB, Adams D, Baumann N, Meininger V et al. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995: 59: 38-44.
5. Burke D, Kiernan M, Mogyoros I, Bostock H. Susceptibility to conduction block: differences in the biophysical properties of cutaneous afferents and motor axons. In: Kimura J, Kaji R, editors. Physiology of ALS and related diseases. Amsterdam: Elsevier, 1997: 41-51.
6. Corbo M, Quattrini A, Lugaresi A, Santoro M, Latov N, Hays AP. Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons. Ann Neurol 1992: 32: 487-93.
7. Gutmann L, Gutmann L. Axonal channelopathies: an evolving concept in the pathogenesis of peripheral nerve disorders. Neurology 1996: 47: 18-21.
8. Harrison BM, Hansen LA, Pollard JD, McLeod JG. Demyelination induced by serum from patients with Guillain-Barré syndrome. Ann Neurol 1984: 15: 163-70.
9. Harvey GK, Toyka KV, Zielasek J, Kiefer R, Simonis C, Hartung HP. Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve 1995: 18: 388-94.
10. Hughes RA, Powell HC, Braheny SL, Brostoff S. Endoneurial injection of antisera to myelin antigens. Muscle Nerve 1985; 8: 516-22.
11. Illa I, Ortiz N, Gallard E, Juarez C, Grau JM, Dalakas MC. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann Neurol 1995: 38: 218-24.
12. Kaji R, Sumner AJ . Ouabain reverses conduction disturbances in single demyelinated nerve libers. Neurology 1989; 39: 1364-8.
13. Kaji R, Shibasaki H, Kimura J. Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy. Neurology 1992: 42: 506-9.
14. Kaji R, Oka N, Tsuji T, Mezaki T, Nishio T, Akiguchi I, et al. Pathological findings at the site of conduction block in multifocal motor neuropathy [see comments]. Ann Neurol 1993; 33: 152-8. Comment in: Ann Neurol 1994; 35: 246-7.
15. Kaji R, Oka N, Tsuji T, Mezaki T, Nishio T, Akiguchi I, et al. Pathological findings at the site of conduction block in multifocal motor neuropathy [see comments]. Ann Neurol 1993; 33: 152-8. Comment in: Ann Neurol 1994; 35: 246-7.
16. Kaji R, Hirota N, Oka N, Kohara N, Watanabe T, Nishio N, et al. Anti-GM1 antibodies and impaired blood-nerve barrier may interfere with remyelination in multifocal motor neuropathy. [Review], Muscle Nerve 1994; 17: 108-10.
17. Kornberg AJ, Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing [see comments]. Muscle Nerve 1994; 17: 100-4. Comment in: Muscle Nerve 1995: 18: 1490-2.
18. Kornberg AJ, Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing [see comments]. Muscle Nerve 1994; 17: 100-4. Comment in: Muscle Nerve 1995: 18: 1490-2.
19. Krarup C, Stewart JD, Sumner AJ, Pestronk A, Lipton SA. A syndrome of asymmetric limb weakness with motor conduction block. Neurology 1990: 40: 118-27.
20. Lafontaine S, Rasminsky M, Saida T, Sumner AJ. Conduction block in rat myelinated fibres following acute exposure to antigalactocerebroside serum. J Physiol (Lond) 1982: 323: 287-306.
21. Lange DJ, Trojaborg W. Do GM1 antibodies induce demyclination? Muscle Nerve 1994; 17: 105-7.
22. Ogawa-Goto K, Funamoto N, Ohta Y, Abe T, Nagashima K. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J Neurochem 1992; 59: 1844-9.
23. Ogino M, Orazio N, Latov N. IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses. J Neuroimmunol 1995; 58: 77-80.
24. Parry GJ. Pure motor neuropathy with multifocal conduction block masquerading as motor neurone disease [abstract]. Muscle Nerve 1985; 8: 617.
25. Parry GJ. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. [Review], Muscle Nerve 1994; 17: 97-9.
26. Parry GJ, Clarke S. Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease. Muscle Nerve 1988; 11: 103-7.
27. Pestronk A. Motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. [Review], Muscle Nerve 1991; 14: 927-36.
28. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neural 1988; 24: 73-8.
29. Pestronk A, Chaudry V, Feldman EL, Griffin, JW, Cornblath DR, Denys EH, et al. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities and high titers of antiglycolipid antibodies. Ann Neurol 1990; 27: 316-26.
30. Redford EJ, Hall SM, Smith KJ. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain 1995; 118: 869-78.
31. Roth G, Rohr J, Magistris MR, Ochsner F. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia: evolution to tetraplegia. Eur Neurol 1986; 25: 416-23.
32. Saida K, Sumner AJ, Saida T, Brown MJ, Silberberg DH. Amiserum-mediated demyelination: relationship between remyelination and functional recovery. Ann Neurol 1980; 8: 12-24.
33. Saida T, Saida K, Silberberg DH, Brown MJ. Experimental allergic neuritis induced by galactocerebroside. Ann Neurol 1981; 9 Suppl: 87-101.
34. Santoro M, Uncini A, Corbo M, Staugaitis SM, Thomas FP, Hays AP, et al. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol 1992; 31: 385-90.
35. Schwerer B, Lassmann H, Kitz K, Bernheimer H. Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by gangliosideantiserum and cholera toxin. Acta Neuropathol (Berl) 1986; 72: 55-61.
36. Stys PK, Waxman SG, Ransom BR. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J Neurosci 1992; 12: 430-9.
37. Sumner AJ, Saida K, Saida T, Silberberg DH, Asbury AK. Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann Neurol 1982; 11: 469-77.
38. Takigawa T, Yasuda H, Kikkawa R, Shigeta Y, Saida T, Kitasato H. Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers [see comments]. Ann Neurol 1995; 37: 436-42. Comment in: Ann Neurol 1995; 37: 421-3.
39. Takigawa T, Yasuda H, Kikkawa R, Shigeta Y, Saida T, Kitasato H. Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers [see comments]. Ann Neurol 1995; 37: 436-42. Comment in: Ann Neurol 1995; 37: 421-3.
40. Thomas FP, Thomas JE, Sadiq SA, van den Berg LH, Roelofs RI, Latov N, et al. Human monoclonal IgM anti-Gal(ß 1-3)GaINAc autoantibodies bind to the surface of bovine spinal motoneurons. J Neuropathol Exp Neurol 1990; 49: 89-95.
41. Thomas FP, Trojaborg W, Nagy C, Santoro M, Sadiq SA, Latov N, et al. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol (Berl) 1991; 82: 378-83.
42. Thomas PK, Claus D, Jaspert A, Workman JM, King RH, Larner AJ, et al. Focal upper limb demyelinating neuropathy. Brain 1996; 119: 765-74.
43. Uncini A, Santoro M, Corbo M, Lugaresi A, Latov N. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 1993; 16: 610-5.
44. Visser LH, Meche;che FG van der, Doom PA van, Meulstee J, Jacobs BC, Oomes PG, et al. Guillain-Barré syndrome without sensory loss (acute motor neuropathy): a subgroup with specific clinical, electrodiagnostic and laboratory features. Brain 1995; 118: 841-7.
45. Waxman SG. Sodium channel blockade by antibodies: a new mechanism of neurological disease? [editorial; comment]. Ann Neurol 1995; 37: 421-3. Comment on: Ann Neurol 1995; 37: 436-42.
46. Waxman SG. Sodium channel blockade by antibodies: a new mechanism of neurological disease? [editorial; comment]. Ann Neurol 1995; 37: 421-3. Comment on: Ann Neurol 1995; 37: 436-42.
47. Wood PM, Schachner M, Bunge RP. Inhibition of Schwann cell myelination in vitro by antibody to the L1 adhesion molecule. J Neurosci 1990; 10: 3635-45.
48. Yoshino H, Miyatani N, Saito M, Ariga T, Lugaresi A, Latov N, et al. Isolated bovine spinal motoneurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy. J Neurochem 1992: 59: 1684-91.
49. Yuki N. Pathogenesis of axonal Guillain-Barré syndrome: hypothesis. Muscle Nerve 1994: 17: 680-2.
50. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis [see comments]. Neurology 1990; 40: 1900-2.
51. Comment in: Neurology 1991: 41: 1327-8.
52. Comment in: Neurology 1991; 41: 1530-1.
53. Comment in: Neurology 1993; 43: 1443-4.